We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The FTC is weighing the merits of conducting a study on the competitive effects of authorized generics, but it is looking for input from drugmakers before deciding how to proceed on the matter, an agency official told a recent industry conference.
Clinical trial data submitted to online registries must contain useful and complete information for the study to be eligible for publication, according to the International Committee of Medical Journal Editors (ICMJE), which accused some manufacturers of providing incomplete data sets.
Generic drugmaker Able Laboratories has suspended its manufacturing operations and recalled its full product line after an internal review of its operations revealed apparent departures from standard operating procedures.
State legislatures are sorting through more 500 separate bills and resolutions affecting the pharmaceutical industry, including proposals to reduce prescription drug spending through generic drug use and preferred drug lists, according to a new report.
A bipartisan group of state legislators has urged the FTC to stop defending the pharmaceutical benefit manager (PBM) industry and to crack down on “deceptive and fraudulent practices” utilized by PBMs.
Pharmaceutical firms not only have to worry about counterfeiters taking a chunk out of their bottom lines, but they must also protect themselves from being held liable for those bogus products, according to an expert on the counterfeit drug trade.
Advocacy groups as well as the manufactures and suppliers of mobility assistive equipment (MAE) are expressing disappointment over new national coverage criteria implemented by the Centers for Medicare and Medicaid Services (CMS) regarding such equipment.
The U.S. Pharmacopeia’s (USP) new human growth hormone (HGH) monograph proves the science is sound for follow-on biologics and that such products can be accurately characterized, contends the Generic Pharmaceutical Association (GPhA).